Replies to post #23224 on BioSante Pharmaceuticals, Inc. (BPAX)

[porgyrusty]

And just yesterday it was $5 though. R/S pricing sits at .236, so needless to say if you held through the last one your more than likely under water, even if you had the ability to down cost average like crazy, and now they're going to do another and give the stock like this and its horrible track record that much room to go even lower and your going to ADD, at $4 to $6 a share, thats just crazy. I honestly hope longs can recoup there money, but its just irrational to think that they do anything for the retail investor.

[snupoled]

Win,
1:6 rs if it slips below a buck....Management has done two
rs already and perception of third one is not good...not saying
3 could be a charm but for most under water already...how high
would stock have to go to recoup principal?
they must be having trouble getting their quorum for merger or we
would have gotten an update I hope you are correct that they are
working on better deal for current shareholders.
If I was sitting on a positive safety study for libigel why would
I value cvrs for 40-million? shareholders taken again?
I believe more strongly than in the morning today,,,that shorts
were starting to settle yesterday...and I would not expect news
this week.....this is going to go one way or the other by atleast
a 50cent-buck swing in short order.worst case scenerio 1:6 rs because news of rs could put us under a buck very quickly if management continues to be less than transparent on company specifics and the wise new investors would wait until after safety study and rs to take positions in new bpax. people often wait for after rs to take positions I have seen this many timesbefore